Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Stock Symbol
-
LTRN on Nasdaq
Aaron G.L. Fletcher - trading volume in the past year for Lantern Pharma Inc.
Holdings reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
429K |
$2.72M |
$6.33 |
May 24, 2024 |
By Bios Fund II QP, LP |
|
|
| Common Stock |
372K |
$2.35M |
$6.33 |
May 23, 2024 |
By Bios Fund I, LP |
|
|
| Common Stock |
218K |
$1.38M |
$6.33 |
May 23, 2024 |
By Bios Fund I QP, LP |
|
|
| Common Stock |
131K |
$832K |
$6.33 |
May 24, 2024 |
By Bios Fund II, LP |
|
|
| Common Stock |
57.5K |
$364K |
$6.33 |
May 24, 2024 |
By Bios Fund II NT, LP |
|
|
| Common Stock |
26.1K |
$165K |
$6.33 |
May 23, 2024 |
By BP Directors, LP |
|
|
| Series A Warrants |
0 |
|
|
Jan 17, 2024 |
By Bios Fund II, LP |
Common Stock |
|
| Series A Warrants |
0 |
|
|
Jan 17, 2024 |
By Bios Fund II NT, LP |
Common Stock |
|
| Series A Warrants |
0 |
|
|
Jan 17, 2024 |
By Bios Fund II QP, LP |
Common Stock |
|
Transactions reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.